DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis.
Costa
Elísio
E
Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal. elisio_costa@hotmail.com
Rocha
Susana
S
Rocha-Pereira
Petronila
P
Reis
Flávio
F
Castro
Elisabeth
E
Teixeira
Frederico
F
Miranda
Vasco
V
do Sameiro Faria
Maria
M
Loureiro
Alfredo
A
Quintanilha
Alexandre
A
Belo
Luís
L
Santos-Silva
Alice
A
D000328:Adult; D000368:Aged; D000483:Alleles; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy / Q000209:etiology / Q000235:genetics; D016022:Case-Control Studies; D027682:Cation Transport Proteins / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005787:Gene Frequency; D014644:Genetic Variation; D006239:Haplotypes; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000235:genetics* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D020641:Polymorphism, Single Nucleotide; D011994:Recombinant Proteins; D006435:Renal Dialysis; D000099236:Solute Carrier Family 11, Member 2
D027682:Cation Transport Proteins; D004921:Erythropoietin; D011994:Recombinant Proteins; D000099236:Solute Carrier Family 11, Member 2